HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
4505studies shown
Showing 229-240 of 4,505
Drug study icon
RecruitingNCT05980949

Safety study of KarXT in Schizophrenia

Official study title

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

Multiple locations, including Anaheim
SchizophreniaMedication studyAges 55–90
Countries
United States, France, Canada, + 27 others
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Other study type icon
Not Yet RecruitingNCT07330843

Assessment and Evolution of Narrative Identity and Its Relationship to Subjective Multidimensional Well-being and Multidimensional Recovery in First Episode Psychosis

Official study title

Évaluation et évolution de l'identité Narrative et de Son Lien Avec le Bien-être Multidimensionnel Subjectif et le rétablissement Multidimensionnel Dans le Premier épisode Psychotique

This study isn't recruiting yet.

In Nîmes
SchizophreniaObservational studyAges 16–30
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nīmes
Behavioral study icon
Not Yet RecruitingNCT07207538

Physical Exercise in people with First Psychotic Episode

Official study title

Impact of Physical Exercise on Telomere Length and Other Markers of Premature Ageing in First-episode Psychosis.

This study isn't recruiting yet.

Location not clearly listed
SchizophreniaInterventional studyAges 18+
Countries
Sponsor
University of Salamanca
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.